Research Commons
      • Browse 
        • Communities & Collections
        • Titles
        • Authors
        • By Issue Date
        • Subjects
        • Types
        • Series
      • Help 
        • About
        • Collection Policy
        • OA Mandate Guidelines
        • Guidelines FAQ
        • Contact Us
      • My Account 
        • Sign In
        • Register
      View Item 
      •   Research Commons
      • University of Waikato Research
      • Arts and Social Sciences
      • National Institute of Demographic and Economic Analysis (NIDEA)
      • NIDEA Papers
      • View Item
      •   Research Commons
      • University of Waikato Research
      • Arts and Social Sciences
      • National Institute of Demographic and Economic Analysis (NIDEA)
      • NIDEA Papers
      • View Item
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      Will access to COVID-19 vaccine in Aotearoa be equitable for priority populations?

      Whitehead, Jesse; Scott, Nina; Atatoa-Carr, Polly; Lawrenson, Ross
      Thumbnail
      Files
      60a4843acd170ba005937da7_5142 - final.pdf
      Published version, 461.0Kb
      Link
       www.nzma.org.nz
      Find in your library  
      Citation
      Export citation
      Whitehead, J., Scott, N., Atatoa-Carr, P., & Lawrenson, R. (2021). Will access to COVID-19 vaccine in Aotearoa be equitable for priority populations? New Zealand Medical Journal, 134(1535), 25–34.
      Permanent Research Commons link: https://hdl.handle.net/10289/14347
      Abstract
      AIM: This research examines the equity implications of the geographic distribution of COVID-19 vaccine delivery locations in Aotearoa New Zealand under five potential scenarios: (1) stadium mega-clinics; (2) Community Based Assessment Centres; (3) GP clinics; (4) community pharmacies; and (5) schools.

      METHOD: We mapped the distribution of Aotearoa New Zealand’s population and the location of potential vaccine delivery facilities under each scenario. Geostatistical techniques identified population clusters for Māori, Pacific peoples and people aged 65 years and over. We calculated travel times between all potential facilities and each Statistical Area 1 in the country. Descriptive statistics indicate the size and proportion of populations that could face significant travel barriers when accessing COVID-19 vaccinations.

      RESULTS: Several areas with significant travel times to potential vaccine delivery sites were also communities identified as having an elevated risk of COVID-19 disease and severity. All potential scenarios for vaccine delivery, with the exception of schools, resulted in travel barriers for a substantial proportion of the population. Overall, these travel time barriers disproportionately burden Māori, older communities and people living in areas of high socioeconomic deprivation.

      CONCLUSION: The equitable delivery of COVID-19 vaccines is key to an elimination strategy. However, if current health services and facilities are used without well-designed and supported outreach services, then access to vaccination is likely to be inequitable.
      Date
      2021
      Type
      Journal Article
      Publisher
      New Zealand Medical Association
      Rights
      This article has been published in the New Zealand Medical Journal. © NZMA. Used with permission.
      Collections
      • NIDEA Papers [99]
      Show full item record  

      Usage

      Downloads, last 12 months
      519
       
       

      Usage Statistics

      For this itemFor all of Research Commons

      The University of Waikato - Te Whare Wānanga o WaikatoFeedback and RequestsCopyright and Legal Statement